Ascherio, A., Willett, W.C., Rimm, E.B., Giovannucci, E.L., Stampfer, M.J., 1994. Dietary iron intake and risk of coronary disease among men. Circulation 89, 969-974.
Bisoendial, R.J., Boekholdt, S.M., Vergeer, M., Stroes, E.S., Kastelein, J.J., 2010. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J 31, 2087-2091.
Devaraj, S., Singh, U., Jialal, I., 2009. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 55, 229-238.
Drakopoulou, M., Toutouzas, K., Stefanadi, E., Tsiamis, E., Tousoulis, D., Stefanadis, C., 2009. Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis 206, 335-339.
Emerging Risk Factors, C., Kaptoge, S., Di Angelantonio, E., Pennells, L., Wood, A.M., White, I.R., et al., 2012. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 367, 1310-1320.
Garg, S., Sarno, G., Garcia-Garcia, H.M., Girasis, C., Wykrzykowska, J., Dawkins, K.D., et al., 2010. A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score. Circ Cardiovasc Interv 3, 317-326.
Gozzelino, R., Arosio, P., 2016. Iron Homeostasis in Health and Disease. Int J Mol Sci 17, 130-143.
Guan, H., Wang, P., Hui, R., Edin, M.L., Zeldin, D.C., Wang, D.W., 2009. Adeno-associated virus-mediated human C-reactive protein gene delivery causes endothelial dysfunction and hypertension in rats. Clin Chem 55, 274-284.
Jialal, I., Devaraj, S., Venugopal, S.K., 2004. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44, 6-11.
Koenig, W., 2013. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol 168, 5126-5134.
Magnusson, M.K., Sigfusson, N., Sigvaldason, H., Johannesson, G.M., Magnusson, S., Thorgeirsson, G., 1994. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 89, 102-108.
Meyers, D.G., 1996. The iron hypothesis--does iron cause atherosclerosis? Clin Cardiol 19, 925-929.
Neven, E., De Schutter, T.M., Behets, G.J., Gupta, A., D'Haese, P.C., 2011. Iron and vascular calcification. Is there a link?Nephrol Dial Transplant 26, 1137-1145.
Pan, H.C., Sheu, W.H., Lee, W.J., Lee, W.L., Liao, Y.C., Wang, K.Y., et al., 2015. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study). Clin Chim Acta 445, 93-100.
Pepys, M.B., Rowe, I.F., Baltz, M.L., 1985. C-reactive protein: binding to lipids and lipoproteins. Int J Clin Exp Pathol 27, 83-111.
Pilote, L., Joseph, L., Bélisle, P., Robinson, K., Van Lente, F., Tager, I.B., 2000. Iron stores and coronary artery disease: A clinical application of a method to incorporate measurement error of the exposure in a logistic regression model. J Clin Epidemiol 53, 809-816.
Reunanen, A., Knekt, P., Marniemi, J., Mäki, J., Maatela, J., Aromaa, A., 1996. Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 50, 431-437.
Salonen, J.T., Nyyssonen, K., Korpela, H., Tuomilehto, J., Seppanen, R., Salonen, R., 1992. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86, 803-811.
Sempos, C.T., Looker, A.C., Gillum, R.F., 1996. Iron and heart disease: the epidemiologic data. Nutr Rev 54, 73-84.
Sempos, C.T., Looker, A.C., Gillum, R.F., McGee, D.L., Vuong, C.V., Johnson, C.L., 2000. Serum Ferritin and Death from all Causes and Cardiovascular Disease: The NHANES II Mortality Study. Ann Epidemiol 10, 441-448.
Serruys, P.W., Morice, M.C., Kappetein, A.P., Colombo, A., Holmes, D.R., Mack, M.J., et al., 2009a. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360, 961-972.
Serruys, P.W., Onuma, Y., Garg, S., Sarno, G., van den Brand, M., Kappetein, A.P., et al., 2009b. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5, 50-56.
Steinberg, D., 1986. Modification of LDL that increases it's atherogenicity. Am J Med 320, 1182-1184.
Sullivan, J., 1981. Iron and the sex difference in heart disease risk. Lancet 317, 1293-1294.
Valgimigli, M., Serruys, P.W., Tsuchida, K., Vaina, S., Morel, M.A., van den Brand, M.J., et al., 2007. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 99, 1072-1081.
van Gaal, W.J., Ponnuthurai, F.A., Selvanayagam, J., Testa, L., Porto, I., Neubauer, S., et al., 2009. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 135, 60-65.
Verma, S., Wang, C.H., Li, S.H., Dumont, A.S., Fedak, P.W., Badiwala, M.V., et al., 2002. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106, 913-919.
Zethelius, B., Berglund, L., Sundstrom, J., Ingelsson, E., Basu, S., Larsson, A., et al., 2008. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358, 2107-2116.